Table 2.
Strain/antibiotic | Antibiotic MIC90 (µg/mL) | Antibiotic MIC90 in FLIP7 presence (µg/mL)1 | FICI | Interaction type | Fold reduction2 |
---|---|---|---|---|---|
Staphylococcus aureus | |||||
Meropenem | 0.02 ± 0.02 | <0.002 | 0.667 | Add | >10 |
Amikacin | 1.88 ± 0.00 | 0.36 ± 0.12 | 0.833 | Add | 5.2 |
Kanamycin | 3.51 ± 1.17 | <0.1 | 0.527 | Add | >35.1 |
Ampicillin | 0.03 ± 0.01 | 0.007 ± 0.001 | 0.542 | Add | 4.3 |
Vancomycin | 0.41 ± 0.19 | 0.12 ± 0.00 | 0.589 | Add | 3.4 |
Benzalkonium Cl | 0.30 ± 0.00 | 0.15 ± 0.00 | 0.750 | Add | 2.0 |
Clindamycin | 75.0 ± 0.0 | 4.70 ± 0.00 | 0.729 | Add | 15.9 |
Erythromycin | 0.94 ± 0.00 | 0.03 ± 0.00 | 0.589 | Add | 31.3 |
Oxacillin | 0.05 ± 0.00 | 0.014 ± 0.002 | 1.042 | Ind | 3.6 |
Chloramphenicol | 4.70 ± 0.00 | 0.60 ± 0.00 | 0.418 | Syn | 7.8 |
Escherichia coli | |||||
Meropenem | 0.03 ± 0.00 | 0.03 ± 0.00 | 1.085 | Ind | 1.0 |
Cefotaxime | 0.09 ± 0.00 | 0.02 ± 0.00 | 0.415 | Syn | 4.5 |
Polymyxin B | 0.34 ± 0.11 | <0.02 | 0.339 | Syn | 17.0 |
Ciprofloxacin | 0.03 ± 0.00 | 0.015 ± 0.00 | 0.666 | Add | 2.0 |
Tetracycline | 0.46 ± 0.00 | 0.03 ± 0.00 | 0.729 | Add | 15.3 |
Gentamicin | 4.69 ± 0.00 | 3.53 ± 1.17 | 1.085 | Ind | 1.3 |
Chloramphenicol | 4.69 ± 0.00 | 0.30 ± 0.00 | 0.670 | Add | 15.6 |
Pseudomonas aeruginosa | |||||
Meropenem | 0.94 ± 0.31 | 0.48 ± 0.00 | 0.516 | Add | 2.0 |
Klebsiella pneumoniae | |||||
Meropenem | 0.01 ± 0.00 | 0.01 ± 0.00 | 1.042 | Ind | 1.0 |
Acinetobacter baumannii | |||||
Meropenem | 0.88 ± 0.13 | 0.03 ± 0.01 | 0.393 | Syn | 29.3 |
Notes:
MIC90 of antibiotic in combination with FLIP7 concentration causing maximum antibiotic fold reduction.
Ratio of antibiotic MIC90 in the absence and presence of FLIP7 concentration causing maximum antibiotic fold reduction. Data presented as mean ± SE.
Abbreviations: TTC, trimethyl tetrazolium chloride; MIC, minimum inhibiting concentration; FICI, fractional inhibitory concentration index; Syn, synergy; Add, additivity; Ind, independence.